The Glutathione System: A New Drug Target in Neuroimmune Disorders

Molecular Neurobiology

Volumn 50, Issue 3, 2014, Pages 1059-1084

  Morris, Gerwyn ^a   Anderson, George ^b   Dean, Olivia ^c   Berk, Michael ^c,d,e   Galecki, Piotr ^f   Martin Subero, Marta ^g   Maes, Michael ^c,h  

^a Tir Na Nog   (United Kingdom)

^b CRC Clincial Research Centre/ Communications   (United Kingdom)

^c DEAKIN UNIVERSITY   (Australia)

^d THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f MEDICAL UNIVERSITY OF LODZ   (Poland)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^h CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Chronic fatigue; Cytokines; Depression; Glutathione; Immune; Inflammation; Myalgic encephalomyelitis; Oxidative and nitrosative stress

Indexed keywords

ANTIOXIDANT; GLUTATHIONE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

BRAIN DISEASES; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; PHYSIOLOGY;

ANTIOXIDANTS; BRAIN DISEASES; GLUTATHIONE; HUMANS; MITOCHONDRIA; NEUROIMMUNOMODULATION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84936747253     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8705-x     Document Type: Review

References (376)

1. Marí M, Morales A, Colell A, García-Ruiz C, Fernández-Checa JC (2009) Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 11:2685–700, PMID: 19558212
2. Lushchak VI (2012) Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids 2012:736837, PMID: 22500213
3. Haddad JJ, Harb HL (2005) l-Gamma-glutamyl-l-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)? Mol Immunol 42:987–1014, PMID: 15829290
4. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84, PMID: 16978905
5. Oja SS, Jenei Z, Janáky R, Saransaari P, Varga V (1994) Thiol reagents and brain glutamate receptors. Proc West Pharmacol Soc 37:59–62
6. Makarov P, Kropf S, Wiswedel I, Augustin W, Schild L (2006) Consumption of redox energy by glutathione metabolism contributes to hypoxia/reoxygenation-induced injury in astrocytes. Mol Cell Biochem 286:95–101, PMID: 16583144
7. Halliwell B, Gutteridge JMC (1989) Free radicals in biology and medicine. Clarendon Press, Oxford
8. Cooper AJ, Pulsinelli WA, Duffy TE (1980) Glutathione and ascorbate during ischemia and postischemic reperfusion in rat brain. J Neurochem 35:1242–5, PMID: 7452315
9. Kumar C, Igbaria A, D’Autreaux B, Planson AG, Junot C, Godat E, Bachhawat AK, Delaunay-Moisan A, Toledano MB (2011) Glutathione revisited: a vital function in iron metabolism and ancillary role in thiol-redox control. EMBO J 30:2044–56. doi:10.1038/emboj.2011.105, PMID: 21478822
10. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P (2008) Redox regulation of cell survival. Antioxid Redox Signal 10:1343–74. doi:10.1089/ars.2007.1957, PMID: 18522489
11. Sheehan D, Meade G, Foley VM, Dowd CA (2001) Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 360:1–16
12. Zhang H, Forman HJ (2009) Redox regulation of gamma-glutamyl transpeptidase. Am J Respir Cell Mol Biol 41:509–15
13. Cooper AJL, Hanigan MH (2010) 4.17—Enzymes involved in processing glutathione conjugates. In: Comprehensive toxicology 4:323–66. 2nd edition
14. McIlwain CC, Townsend DM, Tew KD (2006) Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25:1639–48, PMID: 16550164
15. Coles BF, Morel F, Rauch C, Huber WW, Yang M, Teitel CH, Green B, Lang NP, Kadlubar FF (2001) Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 11:663–9, PMID: 11692074
16. Fernandes AP, Holmgren A (2004) Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 6:63–74, PMID: 14713336
17. Johnson WM, Wilson-Delfosse AL, Mieyal JJ (2012) Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients 4:1399–440. doi:10.3390/nu4101399, PMID: 23201762
18. Peltoniemi M, Kaarteenaho-Wiik R, Säily M, Sormunen R, Pääkkö P, Holmgren A, Soini Y, Kinnula VL (2004) Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo. Hum Pathol 35:1000–7, PMID: 15297967
19. Pai HV, Starke DW, Lesnefsky EJ, Hoppel CL, Mieyal JJ (2007) What is the functional significance of the unique location of glutaredoxin 1 (GRx1) in the intermembrane space of mitochondria? Antioxid Redox Signal 9:2027–33, PMID: 17845131
20. Hinchman CA, Ballatori N (1994) Glutathione conjugation and conversion to mercapturic acids can occur as an intrahepatic process. J Toxicol Environ Health 41:387–409
21. Kalyanaraman B, Karoui H, Singh RJ, Felix CC (1996) Detection of thiyl radical adducts formed during hydroxyl radical- and peroxynitrite-mediated oxidation of thiols—a high resolution ESR spin-trapping study at Q-band (35 Ghz). Anal Biochem 241:75–81
22. Gardner JM, Aust SD (2009) Quantification of hydroxyl radical produced during phacoemulsification. J Cataract Refract Surg 35:2149–53, PMID: 19969222
23. Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT, Butterfield DA (2009) Nitric oxide in cell survival: a Janus molecule. Antioxid Redox Signal 11:2717–39
24. Siems W, Crifo C, Capuozzo E, Uchida K, Grune T, Salerno C (2010) Metabolism of 4-hydroxy-2-nonenal in human polymorphonuclear leukocytes. Arch Biochem Biophys 503:248–52
25. Zhu X, Gallogly MM, Mieyal JJ, Anderson VE, Sayre LM (2009) Covalent cross-linking of glutathione and carnosine to proteins by 4-oxo-2-nonenal. Chem Res Toxicol 22:1050–9
26. Jones DP, Park Y, Gletsu-Miller N, Liang Y, Yu T, Accardi CJ, Ziegler TR (2011) Dietary sulfur amino acid effects on fasting plasma cysteine/cystine redox potential in humans. Nutrition 27:199–205, PMID: 20471805
27. Jones DP (2002) Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol 348:93–112
28. Holmgren A, Sengupta R (2010) The use of thiols by ribonucleotide reductase. Free Radical Biol Med 49:1617–28
29. Yang Y, Sharma R, Sharma A, Awasthi S, Awasthi YC (2003) Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim Pol 50:319–36
30. Zhang D, Lu H, Li J, Shi X, Huang C (2006) Essential roles of ERKs and p38K in up-regulation of GST A1 expression by Maotai content in human hepatoma cell line Hep3B. Mol Cell Biochem 293:161–71, PMID: 16786188
31. Yang Y, Cheng JZ, Singhal SS, Saini M, Pandya U, Awasthi S, Awasthi YC (2001) Role of glutathione S-transferases in protection against lipid peroxidation. Overexpression of hGSTA2-2 in K562 cells protects against hydrogen peroxide-induced apoptosis and inhibits JNK and caspase 3 activation. J Biol Chem 276:19220–30, PMID: 11279091
32. Sakai M, Muramatsu M (2007) Regulation of glutathione transferase P: a tumor marker of hepatocarcinogenesis. Biochem Biophys Res Commun 357:575–8, PMID: 17434454
33. Li Y, Cohenford MA, Dutta U, Dain JA (2008) The structural modification of DNA nucleosides by nonenzymatic glycation: an in vitro study based on the reactions of glyoxal and methylglyoxal with 2′-deoxyguanosine. Anal Bioanal Chem 390:679–88
34. Karlson EW, Watts J, Signorovitch J, Bonetti M, Wright E, Cooper GS, McAlindon TE, Costenbader KH, Massarotti EM, Fitzgerald LM, Jajoo R, Husni ME, Fossel AH, Pankey H, Ding WZ, Knorr R, Condon S, Fraser PA (2007) Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis: results from the Roxbury Lupus Project. Arthritis Rheum 56:244–54, PMID: 17195228
35. Gravina P, Spoletini I, Masini S, Valentini A, Vanni D, Paladini E, Bossu P, Caltagirone C, Federici G, Spalletta G, Bernardini S (2011) Genetic polymorphisms of glutathione S-transferases GSTM1, GSTT1, GSTP1 and GSTA1 as risk factors for schizophrenia. Psychiatry Res 187:454–6
36. Nafissi S, Saadat I, Saadat M (2011) Genetic polymorphisms of glutathione S-transferase Z1 in an Iranian population. Mol Biol Rep 38:3391–4. doi:10.1007/s11033-010-0447-x, PMID: 21107728
37. Williams TA, Mars AE, Buyske SG, Stenroos ES, Wang R, Factura-Santiago MF, Lambert GH, Johnson WG (2007) Risk of autistic disorder in affected offspring of mothers with a glutathione S-transferase P1 haplotype. Arch Pediatr Adolesc Med 161:356–61, PMID: 17404132
38. Rezaei Z, Saadat I, Saadat M (2012) Association between three genetic polymorphisms of glutathione S-transferase Z1 (GSTZ1) and susceptibility to bipolar disorder. Psychiatry Res 30:166–8. doi:10.1016/j.psychres.2011.09.002, PMID: 22374552
39. Lynch T, Price A (2007) The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician 76:391–6
40. Wu Y, Zhang X, Bardag-Gorce F, Robel RC, Aguilo J, Chen L, Zeng Y, Hwang K, French SW, Lu SC, Wan YJ (2004) Retinoid X receptor alpha regulates glutathione homeostasis and xenobiotic detoxification processes in mouse liver. Mol Pharmacol 65:550–7, PMID: 14978233
41. Coles BF, Kadlubar FF (2003) Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors 17:115–30
42. Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88
43. Huang KP, Huang FL (2002) Glutathionylation of proteins by glutathione disulfide S-oxide. Biochem Pharmacol 64:1049–56, PMID: 12213604
44. Poole LB, Karplus PA, Claiborne A (2004) Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol 44:325–47, PMID: 14744249
45. Holmgren A, Lu J (2010) Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem Biophys Res Commun 396:120–4
46. Townsend DM (2008) S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response. Mol Interv 7:313–24
47. Mieyal JJ, Gallogly MM, Qanungo S, Sabens EA, Shelton MD (2008) Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal 10:1941–88
48. Manevich Y, Feinstein SI, Fisher AB (2004) Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proc Natl Acad Sci U S A 101:3780–5, PMID: 15004285
49. Townsend DM, Manevich Y, He L, Hutchens S, Pazoles CJ, Tew KD (2009) Novel role for glutathione S-transferase pi Regulator of protein S-glutathionylation following oxidative and nitrosative stress. J Biol Chem 284:436–45. doi:10.1074/jbc.M805586200, PMID: 18990698
50. Mieyal JJ, Starke DW, Gravina SA, Hocevar BA (1991) Thioltransferase in human red blood cells: kinetics and equilibrium. Biochemistry 30:8883–91
51. Lind C, Gerdes R, Schuppe-Koistinen I, Cotgreave IA (1998) Studies on the mechanism of oxidative modification of human glyceraldehyde-3-phosphate dehydrogenase by glutathione: catalysis by glutaredoxin. Biochem Biophys Res Commun 247:481–6, PMID: 9642155
52. Reddy S, Jones AD, Cross CE, Wong PS, Van Der Vliet A (2000) Inactivation of creatine kinase by S-glutathionylation of the active-site cysteine residue. Biochem J 347:821–7, PMID: 10769188
53. Pineda-Molina E, Klatt P, Vázquez J, Marina A, García de Lacoba M, Pérez-Sala D, Lamas S (2001) Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry 40:14134–42, PMID: 11714266
54. Reynaert NL, van der Vliet A, Guala AS, McGovern T, Hristova M, Pantano C, Heintz NH, Heim J, Ho YS, Matthews DE, Wouters EF, Janssen–Heininger YM (2006) Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci U S A 103:13086–91, PMID: 16916935
55. Rao RK, Clayton LW (2002) Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation. Biochem Biophys Res Commun 293:610–6
56. Taylor ER, Hurrell F, Shannon RJ, Lin TK, Hirst J, Murphy MP (2003) Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem 278:19603–10
57. Chen YR, Chen CL, Pfeiffer DR, Zweier JL (2007) Mitochondrial complex II in the post-ischemic heart: oxidative injury and the role of protein S-glutathionylation. J Biol Chem 282:32640–54
58. Humphries KM, Juliano C, Taylor SS (2002) Regulation of cAMP-dependent protein kinase activity by glutathionylation. J Biol Chem 277:43505–11
59. Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H (2001) Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 276:29596–602
60. Fratelli M, Demol H, Puype M, Casagrande S, Eberini I, Salmona M, Bonetto V, Mengozzi M, Duffieux F, Miclet E, Bachi A, Vanekerckhove J, Gianazza E, Ghezzi P (2002) Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci U S A 99:3505–10
61. Brown GC, Borutaite V (2004) Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim Biophys Acta 1658:44–49, PMID: 15282173
62. Martínez-Ruiz A, Lamas S (2004) S-nitrosylation: a potential new paradigm in signal transduction. Cardiovasc Res 62:43–52, PMID: 15023551
63. Jourd'heuil D, Jourd’heuil FL, Feelisch M (2003) Oxidation and nitrosation of thiols at low micromolar exposure to nitric oxide. Evidence for a free radical mechanis. J Biol Chem 278:15720–6
64. Mannick JB, Schonhoff CM (2002) Nitrosylation: the next phosphorylation? Arch Biochem Biophys 408:1–6, PMID: 12485597
65. Hogg N (2002) The biochemistry and physiology of S-nitrosothiols. Ann Rev Pharmacol Toxicol 42:585–600, PMID: 11807184
66. Martínez-Ruiz A, Lamas S (2007) Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences. Cardiovasc Res 75:220–8, PMID: 17451659
67. Giustarini D, Rossi R, Milzani A, Colombo R, Dalle-Donne I (2004) S-glutathionylation: from redox regulation of protein functions to human diseases. J Cell Mol Med 8:201–12, PMID: 15256068
68. Aracena-Parks P, Goonasekera SA, Gilman C, Dirksen RT, Hidalgo C, Hamilton SL (2006) Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in RyR1. J Biol Chem 281:40354
69. Yang Y, Loscalzo J (2005) S-nitrosoprotein formation and localization in endothelial cells. Proc Natl Acad Sci U S A 102:117–22, PMID: 15618409
70. Qanungo S, Starke DW, Pai HV, Mieyal JJ, Nieminen AL (2007) Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFkappaB. J Biol Chem 282:18427–36
71. Pineda-Molina E, Klatt P, Vazquez J, Marina A, Garcia DL (2001) Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry 40:14134–42
72. Morris G, Maes M (2013) A neuro-immune model of myalgic encephalomyelitis/chronic fatigue syndrome. Metab Brain Dis 28:523–40. doi:10.1007/s11011-012-9324-8, PMID: 22718491
73. Morris G, Maes M (2012) Increased nuclear factor-κB and loss of p53 are key mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Med Hypotheses 79:607–13. doi:10.1016/j.mehy.2012.07.034, PMID: 22951418
74. Marshall HE, Stamler JS (2001) Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40:1688–93, PMID: 11327828
75. Marshall HE, Hess DT, Stamler JS (2004) S-nitrosylation: physiological regulation of NF-kappaB. Proc Natl Acad Sci U S A 101:8841–2, PMID: 15187230
76. Into T, Inomata M, Nakashima M, Shibata K, Häcker H, Matsushita K (2008) Regulation of MyD88-dependent signaling events by S nitrosylation retards toll-like receptor signal transduction and initiation of acute-phase immune responses. Mol Cell Biol 28:1338–47, PMID: 18086890
77. Haddad JJ (2002) The involvement of l-gamma-glutamyl-l-cysteinyl-glycine (glutathione/GSH) in the mechanism of redox signaling mediating MAPK(p38)-dependent regulation of pro-inflammatory cytokine production. Biochem Pharmacol 63:305–20, PMID: 11841806
78. Haddad JJ (2011) A redox microenvironment is essential for MAPK-dependent secretion of pro-inflammatory cytokines: modulation by glutathione (GSH/GSSG) biosynthesis and equilibrium in the alveolar epithelium. Cell Immunol 270:53–61. doi:10.1016/j.cellimm.2011.04.001, PMID: 21550026
79. Gosset P, Wallaert B, Tonnel AB, Fourneau C (1999) Thiol regulation of the production of TNF-α, IL-6 and IL-8 by human alveolar macrophages. Eur Respir J 14:98–105
80. Jeannin P, Delneste Y, Lecoanet-Henchoz S, Gauchat JF, Life P, Holmes D, Bonnefoy JY (1995) Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis. J Exp Med 182:1785–92, PMID: 7500023
81. Neuschwander-Tetri BA, Bellezzo JM, Britton RS, Bacon BR, Fox ES (1996) Thiol regulation of endotoxin-induced release of tumor necrosis factor a from isolated rat Kupffer cells. Biochem J 320:1005–10
82. Chen CY, Huang YL, Lin TH (1998) Association between oxidative stress and cytokine production in nickel-treated rats. Arch Biochem Biophys 356:127–32
83. Helbling B, von Overbeck J, Lauterburg BH (1996) Decreased release of glutathione into the systemic circulation of patients with HIV infection. Eur J Clin Invest 26:38–44, PMID: 8682153
84. Brigelius-Flohé R, Banning A, Kny M, Böl G (2004) Redox events in interleukin-1 signaling. Arch Biochem Biophys 423:66–73
85. Palamara AT, Perno CF, Aquaro S, Bue MC, Dini L, Garaci E (1996) Glutathione inhibits HIV replication by acting at late stages of the virus life cycle. AIDS Res Hum Retroviruses 12:1537–41
86. Novaes R, Freire-de-Lima CG, de Albuquerque RC, Affonso-Mitidieri OR, Espindola O, Lima MA, de Andrada Serpa MJ, Echevarria-Lima J (2013) Modulation of glutathione intracellular levels alters the spontaneous proliferation of lymphocyte from HTLV-1 infected patients. Immunobiol 218:1166–74. doi:10.1016/j.imbio.2013.04.002, PMID: 23669236
87. Fraternale A, Paoletti MF, Casabianca A, Orlandi C, Schiavano GF, Chiarantini L, Clayette P, Oiry J, Vogel JU, Cinatl J Jr, Magnani M (2008) Inhibition of murine AIDS by pro-glutathione (GSH) molecules. Antiviral Res 77:120–7. doi:10.1016/j.antiviral.2007.11.004
88. Cai J, Chen Y, Seth S, Furukawa S, Compans RW, Jones DP (2003) Inhibition of influenza infection by glutathione. Free Radic Biol Med 34:928–36, PMID: 12654482
89. Palamara AT, Perno CF, Ciriolo MR, Dini L, Balestra E, D’Agostini C, Di Francesco P, Favalli C, Rotilio G, Garaci E (1995) Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication. Antiviral Res 27:237–53
90. Garaci E, Palamara AT, Ciriolo MR, D’Agostini C, Abdel-Latif MS, Aquaro S, Lafavia E, Rotilio G (1997) Intracellular GSH content and HIV replication in human macrophages. J Leukoc Biol 62:54–59
91. Wang J, Chen Y, Gao N, Wang Y, Tian Y, Wu J, Zhang J, Zhu J, Fan D, An J (2013) Inhibitory effect of glutathione on oxidative liver injury induced by dengue virus serotype 2 infections in mice. PLoS One 8:e55407. doi:10.1371/journal.pone.0055407
92. Tian Y, Jiang W, Gao N, Zhang J, Chen W, Fan D, Zhou D, An J (2010) Inhibitory effects of glutathione on dengue virus production. Biochem Biophys Res Commun 397:420–4. doi:10.1016/j.bbrc.2010.05.108
93. Angelini G, Gardella S, Ardy M, Ciriolo MR, Filomeni G, Di Trapani G, Clarke F, Sitia R, Rubartelli A (2002) Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci U S A 99:1491–6, PMID: 11792859
94. Ishii T, Hishinuma I, Bannai S, Sugita Y (1981) Mechanism of growth promotion of mouse lymphoma L1210 cells in vitro by feeder layer or 2-mercaptoethanol. J Cell Physiol 107:283–93, PMID: 7251686
95. Yan Z, Garg SK, Kipnis J, Banerjee R (2009) Extracellular redox modulation by regulatory T cells. Nat Chem Biol 5:721–3. doi:10.1038/nchembio.212, PMID: 19718041
96. Sido B, Braunstein J, Breitkreutz R, Herfarth C, Meuer SC (2000) Thiol-mediated redox regulation of intestinal lamina propria T lymphocytes. J Exp Med 192:907–12, PMID: 10993921
97. Garg SK, Yan Z, Vitvitsky V, Banerjee R (2011) Differential dependence on cysteine from transsulfuration versus transport during T cell activation. Antioxid Redox Signal 15:39–47. doi:10.1089/ars.2010.3496, PMID: 20673163
98. Yan Z, Banerjee R (2010) Redox remodeling as an immunoregulatory strategy. Biochem 49:1059–66. doi:10.1021/bi902022n, PMID: 20070126
99. Yan Z, Garg SK, Kipnis J, Banerjee R (2009) Extracellular redox modulation by regulatory T cells. Nat Chem Biol 5:721–3. doi:10.1038/nchembio.212, PMID: 19718041
100. Zahedi Avval F, Holmgren A (2009) Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for mammalian S phase ribonucleotide reductase. J Biol Chem 284:8233–40. doi:10.1074/jbc.M809338200, PMID: 19176520
101. Suthanthiran M, Anderson ME, Sharma VK, Meister A (1990) Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci U S A 87:3343–47, PMID: 1970635
102. Messina JP, Lawrence DA (1989) Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase. J Immunol 143:1974–81
103. Yan Z, Garg SK, Banerjee R (2010) Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells. J Biol Chem 285:41525–32. doi:10.1074/jbc.M110.189944, PMID: 21037289
104. Kamide Y, Utsugi M, Dobashi K, Ono A, Ishizuka T, Hisada T, Koga Y, Uno K, Hamuro J, Mori M (2011) Intracellular glutathione redox status in human dendritic cells regulates IL-27 production and T-cell polarization. Allergy 66:1183–92. doi:10.1111/j.1398-9995.2011.02611.x, PMID: 21545428
105. Murata Y, Ohteki T, Koyasu S, Hamuro J (2002) IFN-gamma and pro-inflammatory cytokine production by antigen-presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension. Eur J Immunol 32:2866–73, PMID: 12355439
106. Palomares T, Alonso-Varona A, Alvarez A, Castro B, Calle Y, Bilbao P (1997) Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells. Clin Exp Metastasis 15:329–37, PMID: 9174132
107. Gmünder H, Roth S, Eck HP, Gallas H, Mihm S, Dröge W (1990) Interleukin-2 mRNA expression, lymphokine production and DNA synthesis in glutathione-depleted T cells. Cell Immunol 130:520–8, PMID: 2208308
108. Yamauchi A, Bloom ET (1997) Control of cell cycle progression in human natural killer cells through redox regulation of expression and phosphorylation of retinoblastoma gene product protein. Blood 89:4092–9, PMID: 9166850
109. Liang CM, Lee N, Cattell D, Liang SM (1989) Glutathione regulates interleukin-2 activity on cytotoxic T-cells. J Biol Chem 264:13519–23
110. Chen J, Stewart V, Spyrou G, Hilberg F, Wagner EF, Alt FW (1994) Generation of normal T and B lymphocytes by c-jun deficient embryonic stem cells. Immunity 1:65–72
111. Pallardó FV, Markovic J, García JL, Viña J (2009) Role of nuclear glutathione as a key regulator of cell proliferation. Mol Aspects Med 30:77–85. doi:10.1016/j.mam.2009.01.001, PMID: 19232542
112. Markovic J, García-Gimenez JL, Gimeno A, Viña J, Pallardó FV (2010) Role of glutathione in cell nucleus. Free Radic Res 44(7):721–33. doi:10.3109/10715762.2010.485989
113. Diaz Vivancos P, Wolff T, Markovic J, Pallardó FV, Foyer CH (2010) A nuclear glutathione cycle within the cell cycle. Biochem J 431:169–78
114. García-Giménez JL, Markovic J, Dasí F, Queval G, Schnaubelt D, Foyer CH, Pallardó FV (2013) Nuclear glutathione. Biochim Biophys Acta 1830:3304–16. doi:10.1016/j.bbagen.2012.10.005, PMID: 23069719
115. Ashtiani HRA, Bakhshandi AK, Rahbar M, Mirzaei A, Malekpour A, Rastegar H (2011) Glutathione, cell proliferation and differentiation. Afr J Biotechnol 10:6348–63
116. Cuadrado A, Garcia-Fernandez LF, Gonzalez L, Suarez Y, Losada A, Alcaide V, Martinez T, Fernandez-Sousa JM, Sanchez-Puelles JM, Munoz A (2003) Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK. J Biol Chem 278:241–50, PMID: 12414812
117. Day RM, Suzuki YJ (2006) Cell proliferation, reactive oxygen and cellular glutathione. Dose Response 3:425–42. doi:10.2203/dose-response.003.03.010, PMID: 18648617
118. Circu ML, Aw TY (2008) Glutathione and apoptosis. Free Radic Res 42:689–706. doi:10.1080/10715760802317663, PMID: 18671159
119. Franco R, Cidlowski JA (2009) Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ 16:1303–14. doi:10.1038/cdd.2009.107, PMID: 19662025
120. Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxidants, and aging. Cell 120:483–95, PMID: 15734681
121. Bertout JA, Patel SA, Simon MC (2008) The impact of O2 availability on human cancer. Nat Rev Cancer 8:967–75
122. Orrenius S, Gogvadze V, Zhivotovsky B (2007) Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47:143–83, PMID: 17029566
123. Kaludercic N, Takimoto E, Nagayama T, Feng N, Lai EW, Bedja D, Chen K, Gabrielson KL, Blakely RD, Shih JC, Pacak K, Kass DA, Di Lisa F, Paolocci N (2010) Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ Res 106:193–202. doi:10.1161/CIRCRESAHA.109.198366, PMID: 19910579
124. Starkov AA, Fiskum G, Chinopoulos C, Lorenzo BJ, Browne SE, Patel MS, Beal MF (2004) Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci 24(36):7779–88, PubMed PMID: 15356189
125. Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, Sadoshima J (2010) NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A 107:15565–70. doi:10.1073/pnas.1002178107, PMID: 20713697
126. Adam-Vizi V, Chinopoulos C (2006) Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci 27:639–45, PMID: 17056127
127. Andreyev AY, Kushnareva YE, Starkov AA (2005) Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc) 70:200–14, PMID: 15807660
128. Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1–13. doi:10.1042/BJ20081386, PMID: 19061483
129. Cox AG, Winterbourn CC, Hampton MB (2009) Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J 425:313–25. doi:10.1042/BJ20091541, PMID: 20025614
130. Aon MA, Cortassa S, O’Rourke B (2010) Redox-optimized ROS balance: a unifying hypothesis. Biochim Biophys Acta 1797:865–77. doi:10.1016/j.bbabio.2010.02.016, PMID: 20175987
131. Aon MA, Stanley BA, Sivakumaran V, Kembro JM, O’Rourke B, Paolocci N, Cortassa S (2012) Glutathione/thioredoxin systems modulate mitochondrial H2O2 emission: an experimental-computational study. J Gen Physiol 139:479–91. doi:10.1085/jgp.201210772, PMID: 22585969
132. Sheeran FL, Rydström J, Shakhparonov MI, Pestov NB, Pepe S (2010) Diminished NADPH transhydrogenase activity and mitochondrial redox regulation in human failing myocardium. Biochim Biophys Acta 1797:1138–48. doi:10.1016/j.bbabio.2010.04.002, PMID: 20388492
133. Drechsel DA, Patel M (2010) Respiration-dependent H2O2 removal in brain mitochondria via the thioredoxin/peroxiredoxin system. J Biol Chem 285:27850–58. doi:10.1074/jbc.M110.101196, PMID: 20558743
134. Go YM, Jones DP (2008) Redox compartmentalization in eukaryotic cells. Biochim Biophys Acta 1780:1273–90. doi:10.1016/j.bbagen.2008.01.011, PMID: 18267127
135. Hu J, Dong L, Outten CE (2008) The redox environment in the mitochondrial intermembrane space is maintained separately from the cytosol and matrix. J Biol Chem 283:29126–34. doi:10.1074/jbc.M803028200, PMID: 18708636
136. Kakkar P, Singh BK (2007) Mitochondria: a hub of redox activities and cellular distress control. Mol Cell Biochem 305:235–53
137. Koehler CM, Beverly K, Leverich EP (2006) Redox pathways in the mitochondrion. Antioxid Redox Signal 8:813–22
138. Pedrajas JR, Kosmidou E, Miranda-Vizuete A, Gustafsson JA, Wright AP, Spyrou G (1999) Identification and functional characterization of a novel mitochondrial thioredoxin system in Saccharomyces cerevisiae. J Biol Chem 274:6366–73
139. Chae HZ, Kang SW, Rhee SG (1999) Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin. Methods Enzymol 300:219–26
140. Orlowski M, Karkowsky A (1976) Glutathione metabolism and some possible functions of glutathione in the nervous system. Int Rev Neurobiol 19:75–121, PMID: 13046
141. Hjelle OP, Rinvik E, Huster D, Reichelt W, Ottersen OP (1998) In: Shaw CA (ed) Glutathione in the nervous system. Taylor & Francis, Washington, pp pp. 63–88
142. Nakanishi S (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258:597–603, PMID: 1329206
143. Récasens M, Mayat E, Vignes M (1992) The multiple excitatory amino acid receptor subtypes and their putative interactions. Mol Neuropharmacol 2:15–31
144. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689–95, PMID: 7901908
145. Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357–66, PMID: 7668820
146. Ogita K, Shuto M, Maeda H, Minami T, Yoneda Y (1998) Possible modulation by glutathione of glutamatergic neurotransmission. In: Shaw CA (ed) Glutathione in the nervous system. Taylor & Francis, Washington, pp pp. 137–161
147. Varga V, Janáky R, Saransaari P, Oja SS (1994) Endogenous gamma-l-glutamyl and beta-l-aspartyl peptides and excitatory aminoacidergic neurotransmission in the brain. Neuropeptides 27:19–26, PMID: 7969817
148. Oja SS, Janáky R, Varga V, Saransaari P (2000) Modulation of glutamate receptor functions by glutathione. Neurochem Int 37:299–306, PMID: 10812215
149. Varga V, Jenei Z, Janáky R, Saransaari P, Oja SS (1997) Glutathione is an endogenous ligand of rat brain N-methyl-d-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors. Neurochem Res 22:1165–71, PMID: 9251108
150. Matsuda T, Shimizu E, Ikehira H, Iyo M, Hashimoto K (2008) Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3 T 1H-MRS study. PLoS One 3:e1944, PMID: 18398470
151. Janáky R, Ogita K, Pasqualotto BA, Bains JS, Oja SS, Yoneda Y, Shaw CA (1999) Glutathione and signal transduction in the mammalian CNS. J Neurochem 73:889–902, PMID: 10461878
152. Varga V, Janáky R, Marnela KM, Gulyás J, Kontro P, Oja SS (1989) Displacement of excitatory amino acid receptor ligands by acidic oligopeptides. Neurochem Res 14:1223–7, PMID: 2576463
153. Jenei Z, Janáky R, Varga V, Saransaari P, Oja SS (1998) Interference of S-alkyl derivatives of glutathione with brain ionotropic glutamate receptors. Neurochem Res 23:1085–91, PMID: 9704598
154. Gilbert KR, Aizenman E, Reynolds IJ (1991) Oxidized glutathione modulates N-methyl-d-aspartate- and depolarization-induced increases in intracellular Ca2+ in cultured rat forebrain neurons. Neurosci Lett 133:11–4, PMID: 1838798
155. Cooper AJL (1997) Role of astrocytes in maintaining cerebral glutathione homeostasis and in protecting the brain against xenobiotics and oxidative stress. In: Shaw CA (ed) Glutathione in the nervous system. Taylor and Francis, Washington, pp 91-1–115
156. Levy DI, Sucher NJ, Lipton SA (1991) Glutathione prevents N-methyl-d-aspartate receptor-mediated neurotoxicity. Neuroreport 2:345–47, PMID: 1832987
157. Owe SG, Marcaggi P, Attwell D (2006) The ionic stoichiometry of the GLAST glutamate transporter in salamander retinal glia. J Physiol 577:591–9, PMID: 17008380
158. Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC (1995) Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci 15:1835–53, PMID: 7891138
159. Tanaka K (2000) Functions of glutamate transporters in the brain. Neurosci Res 37:15–9, PMID: 10802340
160. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori S, Takimoto M, Wada K (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276:1699–1702, PMID: 9180080
161. Takaki J, Fujimori K, Miura M, Suzuki T, Sekino Y, Sato K (2012) l-glutamate released from activated microglia downregulates astrocytic l-glutamate transporter expression in neuroinflammation: the ‘collusion’ hypothesis for increased extracellular l-glutamate concentration in neuroinflammation. J Neuroinflammation 9:275. doi:10.1186/1742-2094-9-275. PMID: 23259598
162. c. Pflugers Arch 442:286–96
163. Sato H, Shiiya A, Kimata M, Maebara K, Tamba M, Sakakura Y, Makino N, Sugiyama F, Yagami K, Moriguchi T, Takahashi S, Bannai S (2005) Redox imbalance in cystine/glutamate transporter-deficient mice. J Biol Chem 280:37423–9, PMID: 16144837
164. Allen JW, Shanker G, Aschner M (2001) Methylmercury inhibits the in vitro uptake of the glutathione precursor, cystine, in astrocytes, but not in neurons. Brain Res 894:131–40
165. Qin S, Colin C, Hinners I, Gervais A, Cheret C, Mallat M (2006) System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40. J Neurosci 26:3345–56, PMID: 16554485
166. Barger SW, Goodwin ME, Porter MM, Beggs ML (2007) Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J Neurochem 101:1205–13
167. Kidd PM (2003) Glutathione: Systemic protectant against oxidative and free radical damage. Alt Med Rev 2:155–76
168. Gardner JM, Aust SD (2009) Quantification of hydroxyl radical produced during phacoemulsification. J Cataract Refract Surg 35:2149–53
169. Sagone AL Jr, Husney RM, O’Dorisio MS, Metz EN (1984) Mechanisms for the oxidation of reduced gluthathione by stimulated granulocytes. Blood 63:96–104
170. Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT, Butterfield DA (2009) Nitric oxide in cell survival: a Janus molecule. Antioxid Redox Signal 11:2717–39
171. Chang HL, Dedon PC, Deen WM (2008) Kinetic analysis of intracellular concentrations of reactive nitrogen species. Chem Res Toxicol 21:2134–47
172. Siems W, Crifo C, Capuozzo E, Uchida K, Grune T, Salerno C (2010) Metabolism of 4-hydroxy-2-nonenal in human polymorphonuclear leukocytes. Arch Biochem Biophys 503:248–52
173. Zhu X, Gallogly MM, Mieyal JJ, Anderson VE, Sayre LM (2009) Covalent cross-linking of glutathione and carnosine to proteins by 4-oxo-2-nonenal. Chem Res Toxicol 22:1050–9
174. Lushchak VI (2011) Adaptive response to oxidative stress: bacteria, fungi, plants and animals. Comp Biochem Physiol C Toxicol Pharmacol 153:175–190
175. Lushchak VI (2011) Environmentally induced oxidative stress in aquatic animals. Aquatic Toxicol 101:13–30
176. Belrose JC, Xie YF, Gierszewski LJ, MacDonald JF, Jackson MF (2012) Loss of glutathione homeostasis associated with neuronal senescence facilitates TRPM2 channel activation in cultured hippocampal pyramidal neurons. Mol Brain 5:11. doi:10.1186/1756-6606-5-11, PMID: 22487454
177. Dringen R, Hirrlinger J (2003) Glutathione pathways in the brain. Biol Chem 384:505–16
178. Lu GD, Shen HM, Chung MC, Ong CN (2007) Critical role of oxidative stress and sustained JNK activation in aloe-emodin-mediated apoptotic cell death in human hepatoma cells. Carcinogenesis 28:1937–45, PMID: 17698970
179. Neuschwander-Tetri BA, Bellezzo JM, Britton RS, Bacon BR, Fox ES (1996) Thiol regulation of endotoxin-induced release of tumour necrosis factor alpha from isolated rat Kupffer cells. Biochem J 320:1005–10, PMID: 9003392
180. Nikulina MA, Andersen HU, Karlsen AE, Darville MI, Eizirik DL, Mandrup-Poluson T (2000) Glutathione depletion inhibits interleukin 1 beta-stimulated nitric oxide production by reducing inducible nitric oxide synthase gene expression. Cytokine+ 12:1391–4
181. Peristeris P, Clark BD, Gatti S, Faggini R, Mantovani A, Mengozzi M, Orencole SF, Sironi M, Ghezzi P (1992) N-acetylcysteine and glutathione as inhibitors of tumour necrosis factor production. Cell Immunol 140:390–9
182. Robinson MK, Roderick ML, Jacobs DO, Rounds JD, Collins KH, Saporoschetz IB, Mannick JA, Wilmore DW (1993) Glutathione depletion in rats impairs T-cell and macrophage immune function. Arch Surg 128:29–35
183. Komatsu H, Hoshino A, Funayama M, Kawahara K, Obala F (2003) Oxidative modulation of the glutathione-redox couple enhances lipopolysaccharide-induced interleukin 12 P40 production by a mouse macrophage cell line, J774A.1. Free Radic Res 37:293–9
184. Grimble RF (2006) The effects of sulfur amino acid intake on immune function in humans. J Nutr 136:1660S–5S, PMID: 16702336
185. Peterson JD, Herzenberg LA, Vasquez K, Waltenbaugh C (1998) Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci U S A 95:3071–6, PMID: 9501217
186. Won HY, Sohn JH, Min HJ, Lee K, Woo HA, Ho YS, Park JW, Rhee SG, Hwang ES (2010) Glutathione peroxidase 1 deficiency attenuates allergen-induced airway inflammation by suppressing Th2 and Th17 cell development. Antioxid Redox Signal 13:575–87. doi:10.1089/ars.2009.2989, PMID: 20367278
187. Li W, Busu C, Circu ML, Aw TY (2012) Glutathione in cerebral microvascular endothelial biology and pathobiology: implications for brain homeostasis. Int J Cell Biol 2012:434971. doi:10.1155/2012/434971, PMID: 22745639
188. Velu CS, Niture SK, Doneanu CE, Pattabiraman N, Srivenugopal KS (2007) Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochem 46:7765–80, PMID: 17555331
189. Qanungo S, Starke DW, Pai HV, Mieyal JJ, Nieminen AL (2007) Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFkappaB. J Biol Chem 282:18427–36, PMID: 17468103
190. Staal FJ (1998) Glutathione and HIV infection: reduced reduced, or increased oxidized? Eur J Clin Invest 28:194–6, PMID: 9568464
191. Kurdi M, Sivakumaran V, Duhé RJ, Aon MA, Paolocci N, Booz GW (2012) Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes. Int J Biochem Cell Biol 44:2106–15. doi:10.1016/j.biocel.2012.08.016, PMID: 22939972
192. Zeevalk GD, Manzino L, Sonsalla PK, Bernard LP (2007) Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson’s disease. Exp Neurol 203(2):512–20, PMID: 17049515
193. Shen H, Liu Z (2006) JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Rad Biol Med 40:928–39
194. Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, Przedborski S, Rakic P, Flavell RA (2004) JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson’s disease. Proc Natl Acad Sci U S A 101:665–70
195. Garcia-Gimenez JL, Markovic J, Dasi F, Queval G, Schnaubelt D, Foyer CH, Pallardo FV (2013) Nuclear glutathione. Biochim Biophys Acta 1830:3304–16
196. Markovic J, Mora NJ, Broseta AM, Gimeno A, de-la Concepción N, Vina J, Pallardo FV (2009) The depletion of nuclear glutathione impairs cell proliferation in 3 t3 fibroblasts. PLoS One 4:e6413. doi:10.1371/journal.pone.0006413
197. Takahashi T, Tabuchi T, Tamaki Y, Kosaka K, Takikawa Y, Satoh T (2009) Carnosic acid and carnosol inhibit adipocyte differentiation in mouse 3 T3-L1 cells through induction of phase2 enzymes and activation of glutathione metabolism. Biochem Biophys Res Commun 382:549–54. doi:10.1016/j.bbrc.2009.03.059, PMID: 19289108
198. Messina JP, Lawrence DA (1989) Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase. J Immunol 143:1974–81, PMID: 2789253
199. Markovic J, Borrás C, Ortega A, Sastre J, Viña J, Pallardó FV (2007) Glutathione is recruited into the nucleus in early phases of cell proliferation. J Biol Chem 282:20416–24, PMID: 17452333
200. Atkuri KR, Cowan TM, Kwan T, Ng A, Herzenberg LA, Herzenberg LA, Enns GM (2009) Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia. Proc Natl Acad Sci U S A 106:3941–5. doi:10.1073/pnas.0813409106, PMID: 19223582
201. Vali S, Mythri RB, Jagatha B, Padiadpu J, Ramanujan KS, Andersen JK, Gorin F, Bharath MM (2007) Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson’s disease: a dynamic model. Neuroscience 149:917–30, PMID: 17936517
202. Hargreaves IP, Sheena Y, Land JM, Heales SJ (2005) Glutathione deficiency in patients with mitochondrial disease: implications for pathogenesis and treatment. J Inherit Metab Dis 28:81–8, PMID: 15702408
203. Pastore A, Petrillo S, Tozzi G, Carrozzo R, Martinelli D, Dionisi-Vici C, Di Giovamberardino G, Ceravolo F, Klein MB, Miller G, Enns GM, Bertini E, Piemonte F (2013) Glutathione: a redox signature in monitoring EPI-743 therapy in children with mitochondrial encephalomyopathies. Mol Genet Metab 109:208–14. doi:10.1016/j.ymgme.2013.03.011, PMID: 23583222
204. Salmi H, Leonard JV, Rahman S, Lapatto R (2012) Plasma thiol status is altered in children with mitochondrial diseases. Scand J Clin Lab Invest 72:152–7. doi:10.3109/00365513.2011.646299, PMID: 22208644
205. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA (2007) N-acetylcysteine—a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 7:355–9, PMID: 17602868
206. Waly MI, Hornig M, Trivedi M, Hodgson N, Kini R, Ohta A, Deth R (2012) Prenatal and postnatal epigenetic programming: implications for GI, immune, and neuronal function in autism. Autism Res Treat 2012:190930. doi:10.1155/2012/190930, PMID: 22934169
207. Kang PT, Zhang L, Chen CL, Chen J, Green KB, Chen YR (2012) Protein thiyl radical mediates S-glutathionylation of complex I. Free Radic Biol Med 53:962–73. doi:10.1016/j.freeradbiomed.2012.05.025, PMID: 22634394
208. Townsend DM, Manevich Y, He L, Hutchens S, Pazoles CJ, Tew KD (2009) Novel role for glutathione S-transferase piRegulator of protein S-glutathionylation following oxidative and nitrosative stress. J Biol Chem 284:436–45. doi:10.1074/jbc.M805586200, PMID: 18990698
209. Borutaite V, Brown GC (2007) Mitochondrial regulation of caspase activation by cytochrome oxidase and tetramethylphenylenediamine via cytosolic cytochrome c redox state. J Biol Chem 282:31124–30, PMID: 17690099
210. Vaughn AE, Deshmukh M (2008) Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat Cell Biol 10:1477–83. doi:10.1038/ncb1807, PMID: 19029908
211. Kizhakkayil J, Thayyullathil F, Chathoth S, Hago A, Patel M, Galadari S (2012) Glutathione regulates caspase-dependent ceramide production and curcumin-induced apoptosis in human leukemic cells. Free Radic Biol Med 52:1854–64. doi:10.1016/j.freeradbiomed.2012.02.026, PMID: 22387197
212. Martín SF, Sawai H, Villalba JM, Hannun YA (2007) Redox regulation of neutral sphingomyelinase-1 activity in HEK293 cells through a GSH-dependent mechanism. Arch Biochem Biophys 459:295–300, PMID: 17169322
213. Lou H, Kaplowitz N (2007) Glutathione depletion down-regulates tumor necrosis factor alpha-induced NF-kappaB activity via IkappaB kinase-dependent and -independent mechanisms. J Biol Chem 282:29470–81, PMID: 17690092
214. Franco R, Cidlowski JA (2009) Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ 16:1303–14. doi:10.1038/cdd.2009.107, PMID: 19662025
215. Allen EM, Mieyal JJ (2012) Protein-thiol oxidation and cell death: regulatory role of glutaredoxins. Antioxid Redox Signal 17:1748–63. doi:10.1089/ars.2012.4644, PMID: 22530666
216. Franco R, Panayiotidis MI, Cidlowski JA (2007) Glutathione depletion is necessary for apoptosis in lymphoid cells independent of reactive oxygen species formation. J Biol Chem 282:30452–65, PMID: 17724027
217. Ji L, Shen K, Jiang P, Morahan G, Wang Z (2011) Critical roles of cellular glutathione homeostasis and jnk activation in andrographolide-mediated apoptotic cell death in human hepatoma cells. Mol Carcinog 50:580–91. doi:10.1002/mc.20741, PMID: 21319226
218. Yue P, Zhou Z, Khuri FR, Sun SY (2006) Depletion of intracellular glutathione contributes to JNK-mediated death receptor 5 upregulation and apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me). Cancer Biol Ther 5:492–7, PMID: 16582599
219. Haouzi D, Lekehal M, Tinel M, Vadrot N, Caussanel L, Lettéron P, Moreau A, Feldmann G, Fau D, Pessayre D (2001) Prolonged, but not acute, glutathione depletion promotes Fas-mediated mitochondrial permeability transition and apoptosis in mice. Hepatology 33:1181–8
220. Armstrong JS, Jones DP (2002) Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in Bcl-2 overexpressing HL60 cells. FASEB J 16:1263–5, PMID: 12060676
221. Chernyak BV (1997) Redox regulation of the mitochondrial permeability transition pore. Biosci Rep 17:293–302, PMID: 9337484
222. Sato T, Machida T, Takahashi S, Iyama S, Sato Y, Kuribayashi K, Takada K, Oku T, Kawano Y, Okamoto T, Takimoto R, Matsunaga T, Takayama T, Takahashi M, Kato J, Niitsu Y (2004) Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells. J Immunol 173:285–96, PMID: 15210786
223. D’Alessio M, De Nicola M, Coppola S, Gualandi G, Pugliese L, Cerella C, Cristofanon S, Civitareale P, Ciriolo MR, Bergamaschi A, Magrini A, Ghibelli L (2005) Oxidative Bax dimerization promotes its translocation to mitochondria independently of apoptosis. FASEB J 19:1504–6, PMID: 15972297
224. Kanno T, Nishizaki T (2001) Sphingosine induces apoptosis in hippocampal neurons and astrocytes by activating caspase-3/-9 via a mitochondrial pathway linked to SDK/14-3-3 protein/Bax/cytochrome c. J Cell Physiol 226:2329–37. doi:10.1002/jcp.22571, PMID: 21660956
225. Guha P, Dey A, Sen R, Chatterjee M, Chattopadhyay S, Bandyopadhyay SK (2011) Intracellular GSH depletion triggered mitochondrial Bax translocation to accomplish resveratrol-induced apoptosis in the U937 cell line. J Pharmacol Exp Ther 336:206–14. doi:10.1124/jpet.110.171983, PMID: 20876229
226. Giorgi C, Baldassari F, Bononi A, Bonora M, De Marchi E, Marchi S, Missiroli S, Patergnani S, Rimessi A, Suski JM, Wieckowski MR, Pinton P (2012) Mitochondrial Ca(2+) and apoptosis. Cell Calcium 52:36–43. doi:10.1016/j.ceca.2012.02.008, PMID: 22480931
227. Jin M, Yaung J, Kannan R, He S, Ryan SJ, Hinton DR (2005) Hepatocyte growth factor protects RPE cells from apoptosis induced by glutathione depletion. Invest Ophthalmol Vis Sci 46:4311–19, PMID: 16249513
228. Robillard JM, Gordon GR, Choi HB, Christie BR, MacVicar BA (2011) Glutathione restores the mechanism of synaptic plasticity in aged mice to that of the adult. PLoS One 6:e20676. doi:10.1371/journal.pone.0020676, PMID: 21655192
229. Steullet P, Neijt HC, Cuénod M, Do KQ (2006) Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia. Neuroscience 137:807–19, PMID: 16330153
230. Abramov AY, Canevari L, Duchen MR (2003) Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J Neurosci 23:5088–95, PMID: 12832532
231. Dallas M, Boycott HE, Atkinson L, Miller A, Boyle JP, Pearson HA, Peers C (2007) Hypoxia suppresses glutamate transport in astrocytes. J Neurosci 27:3946–55, PMID: 17428968
232. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2:1547–58, PMID: 2576375
233. Juurlink BH (1997) Response of glial cells to ischemia: roles of reactive oxygen species and glutathione. Neurosci Biobehav Rev 21:151–66, PMID: 9062938
234. Stewart VC, Stone R, Gegg ME, Sharpe MA, Hurst RD, Clark JB, Heales SJ (2002) Preservation of extracellular glutathione by an astrocyte derived factor with properties comparable to extracellular superoxide dismutase. J Neurochem 83:984–91, PMID: 12421371
235. Dringen R, Pfeiffer B, Hamprecht B (1999) Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci 19:562–9, PMID: 9880576
236. Dringen R, Gutterer JM, Gros C, Hirrlinger J (2001) Aminopeptidase N mediates the utilization of the GSH precursor CysGly by cultured neurons. J Neurosci Res 66:1003–8, PMID: 11746430
237. Aoyama K, Watabe M, Nakaki T (2008) Regulation of neuronal glutathione synthesis. J Pharmacol Sci 108:227–38, PMID: 19008644
238. Lertratanangkoon K, Wu CJ, Savaraj N, Thomas ML (1997) Alterations of DNA methylation by glutathione depletion. Cancer Lett 120:149–56, PMID: 9461031
239. Campos AC, Molognoni F, Melo FH, Galdieri LC, Carneiro CR, D’Almeida V, Correa M, Jasiulionis MG (2007) Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation. Neoplasia 9:1111–21, PMID: 18084618
240. Hartnett L, Egan LJ (2012) Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis 33:723–31. doi:10.1093/carcin/bgs006, PMID: 22235026
241. Wachsman JT (1997) DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis. Mutat Res 375:1–8, PMID: 9129674
242. Weitzman SA, Turk PW, Milkowski DH, Kozlowski K (1994) Free radical adducts induce alterations in DNA cytosine methylation. Proc Natl Acad Sci U S A 91:1261–4, PMID: 8108398
243. Kuchino Y, Mori F, Kasai H, Inoue H, Iwai S, Miura K, Ohtsuka E, Nishimura S (1987) Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 327:77–9, PMID: 3574469
244. Hitchler MJ, Domann FE (2007) An epigenetic perspective on the free radical theory of development. Free Radic Biol Med 43:1023–36, PMID: 17761298
245. McCaddon A, Regland B, Hudson P, Davies G (2002) Functional vitamin B(12) deficiency and Alzheimer disease. Neurology 58:1395–9, PMID: 12011287
246. Deth R, Muratore C, Benzecry J, Power-Charnitsky VA, Waly M (2008)) How environmenta and genetic factors combine to cause autism: a redox/methylation hypothesis. Neurotoxicol 29:190–201, PMID: 1803-1821
247. Looney JM, Childs HM (1934) The lactic acid and glutathione content of the blood of schizophrenic patients. J Clin Invest 13:963–8, PMID: 16694262
248. Rybka J, Kędziora-Kornatowska K, Banaś-Leżańska P, Majsterek I, Carvalho LA, Cattaneo A, Anacker C, Kędziora J (2013) Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression. Free Radic Biol Med 63:187–194. doi:10.1016/j.freeradbiomed.2013.05.019, PMID: 23707456
249. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2011) Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis/chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression. Neuro Endocrinol Lett 32:133–40, PMID: 21552194
250. Kaddurah-Daouk R, Yuan P, Boyle SH, Matson W, Wang Z, Zeng ZB, Zhu H, Dougherty GG, Yao JK, Chen G, Guitart X, Carlson PJ, Neumeister A, Zarate C, Krishnan RR, Manji HK, Drevets W (2012) Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile. Sci Rep 2:667, PMID: 22993692
251. Stefanescu C, Ciobica A (2012) The relevance of oxidative stress status in first episode and recurrent depression. J Affect Disorder 20;143(1-3):34–8. doi:10.1016/j.jad.2012.05.022
252. Gibson SA, Korade Ž, Shelton RC (2012) Oxidative stress and glutathione response in tissue cultures from persons with major depression. J Psychiatr Res 46:1326–32. doi:10.1016/j.jpsychires.2012.06.008, PMID: 22841833
253. Gawryluk JW, Wang JF, Andreazza AC, Shao L, Yatham LN, Young LT (2011) Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia. Int J Neuropsychopharmacol 14:1069–74. doi:10.1017/S1461145711000617, PMID: 21733244
254. Gawryluk JW, Wang JF, Andreazza AC, Shao L, Young LT (2011) Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 14:123–30. doi:10.1017/S1461145710000805, PMID: 20633320
255. Rose S, Melnyk S, Pavliv O, Bai S, Nick TG, Frye RE, James SJ (2012) Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry 2:e134. doi:10.1038/tp.2012.61, PMID: 22781167
256. Mathew SJ, Murrough JW, Mao X, Pillemer S, Shungu DC (2010) Proton magnetic resonance spectroscopy measurement of brain glutathione supports increased oxidative stress in major depressive Ddsorder. 49th American College of Neuropsychopharmacology Annual Meeting, Miami, Fl., December 5. Poster Session 1: 153
257. Do KQ, Trabesinger AH, Kirsten-Krüger M, Lauer CJ, Dydak U, Hell D, Holsboer F, Boesiger P, Cuénod M (2000) Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 12:3721–8, PMID: 11029642
258. Matsuzawa D, Obata T, Shirayama Y, Nonaka H, Kanazawa Y, Yoshitome E, Takanashi J, Matsuda T, Shimizu E, Ikehira H, Iyo M, Hashimoto K (2008) Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3 T 1H-MRS study. PLoS One 3:e1944, PMID: 18398470
259. Berk M, Johansson S, Wray NR, Williams L, Olsson C, Haavik J, Bjerkeset O (2011) Glutamate cysteine ligase (GCL) and self reported depression: an association study from the HUNT. J Affect Disord 131:207–13. doi:10.1016/j.jad.2010.12.019, PMID: 21277635
260. Maes M, Van de Vyvere J, Vandoolaeghe E, Bril T, Demedts P, Wauters A, Neels H (1996) Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process. J Affect Disord 40:23–33. doi:10.1016/0165-0327(96)00038-9. PMID: 8882911
261. Edwards R, Peet M, Shay J, Horrobin D (1998) Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 48:149–55. doi:10.1016/S0165-0327(97)00166-3. PMID: 9543204
262. Peet M, Murphy B, Shay J, Horrobin D (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43:315–9, PMID: 9513745
263. Richards RS, Wang L, Jelinek H (2007) Erythrocyte oxidative damage in chronic fatigue syndrome. Arch Med Res 38:94–8
264. Raftos JE, Whillier S, Kuchel PW (2010) Glutathione synthesis and turnover in the human erythrocyte: alignment of a model based on detailed enzyme kinetics with experimental data. J Biol Chem 285:23557–67. doi:10.1074/jbc.M109.067017, PMID: 20498365
265. Tavazzi B, Amorini AM, Fazzina G, Di Pierro D, Tuttobene M, Giardina B, Lazzarino G (2001) Oxidative stress induces impairment of human erythrocyte energy metabolism through the oxygen radical-mediated direct activation of AMP-deaminase. J Biol Chem 276:48083–92, PMID: 11675377
266. Pandey KB, Rizvi SI (2010) Markers of oxidative stress in erythrocytes and plasma during aging in humans. Oxid Med Cell Longev 3:2–12. doi:10.4161/oxim.3.1.10476, PMID: 20716923
267. Morris G, Maes M (2013) Case definitions and diagnostic criteria for myalgic encephalomyelitis and chronic fatigue syndrome: from clinical-consensus to evidence-based case definitions. Neuro-Endocrinol Lett 34:185–99, PMID: 23685416
268. Shungu DC, Weiduschat N, Murrough JW, Mao X, Pillemer S, Dyke JP, Medow MS, Natelson BH, Stewart JM, Mathew SJ (2012) Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed 25:1073–87. doi:10.1002/nbm.2772, PMID: 22281935
269. Puri BK, Agour M, Gunatilake KD, Fernando KA, Gurusinghe AI, Treasaden IH (2009) An in vivo proton neurospectroscopy study of cerebral oxidative stress in myalgic encephalomyelitis (chronic fatigue syndrome). Prostaglandins Leukot Essent Fatty Acids 81:303–5. doi:10.1016/j.plefa.2009.10.002, PMID: 19906518
270. Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJ (2005) Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med 39:584–9, PMID: 16085177
271. Richards RS, Roberts TK, Dunstan RH, McGregor NR, Butt HL (2000) Free radicals in chronic fatigue syndrome: cause or effect? Redox Rep 5:146–7
272. Fulle S, Mecocci P, Fanó G, Vecchiet I, Vecchini A, Racciotti D, Cherubini A, Pizzigallo E, Vecchiet L, Senin U, Beal MF (2000) Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. Free Radic Biol Med 29:1252–9, PMID: 11118815
273. Logan AC, Wong C (2001) Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern Med Rev 6:450–9, PMID: 11703165
274. Jammes Y, Steinberg JG, Mambrini O, Brégeon F, Delliaux S (2005) Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J Intern Med 257:299–310, PMID: 15715687
275. Bested AC, Saunders PR, Logan AC (2001) Chronic fatigue syndrome: neurological findings may be related to blood–brain barrier permeability. Med Hypotheses 57:231–7, PMID: 11461179
276. Kim HG, Cho JH, Yoo SR, Lee JS, Han JM, Lee NH, Ahn YC, Son CG (2013) Antifatigue effects of Panax ginseng C.A. Meyer: a randomised, double-blind, placebo-controlled trial. PLoS One 8:e61271
277. Kim HG, Yoo SR, Park HJ, Son CG (2013) Indirect moxibustion (CV4 and CV8) ameliorates chronic fatigue: a randomized, double-blind, controlled study. J Altern Complement Med 19:134–40. doi:10.1089/acm.2011.0503, PMID: 22757691
278. Ding W, Liu Y (2011) Genistein attenuates genioglossus muscle fatigue under chronic intermittent hypoxia by down-regulation of oxidative stress level and up-regulation of antioxidant enzyme activity through ERK1/2 signaling pathway. Oral Dis 17:677–84. doi:10.1111/j.1601-0825.2011.01822.x, PMID: 21729219
279. Liu CZ, Lei B (2012) Effect of acupuncture on serum malonaldehyde content, superoxide dismutase and glutathione peroxidase activity in chronic fatigue syndrome rats. Zhen Ci Yan Jiu 37:38–40, PMID: 22574567
280. Sachdeva AK, Kuhad A, Tiwari V, Chopra K (2009) Epigallocatechin gallate ameliorates chronic fatigue syndrome in mice: behavioral and biochemical evidence. Behav Brain Res 205:414–20. doi:10.1016/j.bbr.2009.07.020, PMID: 19643148
281. Kumar A, Garg R (2009) Protective effects of antidepressants against chronic fatigue syndrome-induced behavioral changes and biochemical alterations. Fundam Clin Pharmacol 23:89–95. doi:10.1111/j.1472-8206.2008.00638.x, PMID: 19207541
282. Kumar A, Garg R (2008) Kumar P (2008) Nitric oxide modulation mediates the protective effect of trazodone in a mouse model of chronic fatigue syndrome. Pharmacol Rep 60(5):664–72, PubMed PMID: 19066412
283. Dhir A, Kulkarni SK (2008) Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice. Pharmacol, Biochem Behav 89:563–71. doi:10.1016/j.pbb.2008.02.011, PMID: 18336891
284. Singal A, Kaur S, Tirkey N, Chopra K (2005) Green tea extract and catechin ameliorate chronic fatigue-induced oxidative stress in mice. J Med Food 8:47–52, PMID: 15857209
285. Singh A, Garg V, Gupta S, Kulkarni SK (2002) Role of antioxidants in chronic fatigue syndrome in mice. Indian J Exp Biol 40:1240–4, PMID:13677625
286. Morris G, Maes M (2013) Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics. BMC Med 11:205. doi:10.1186/1741-7015-11-205, PMID: 24229326
287. Morris G, Maes M (2014) Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis 29(1):19–36
288. Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M (2011) In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 35(3):744–59. doi:10.1016/j.pnpbp.2010.08.026, PubMed PMID: 20828592
289. Vialou V, Feng J, Robison AJ, Nestler EJ (2013) Epigenetic mechanisms of depression and antidepressant action. Annu Rev Pharmacol Toxicol 53:59–87. doi:10.1146/annurev-pharmtox-010611-134540, PMID: 23020296
290. Menzies V, Lyon DE, Archer KJ, Zhou Q, Brumelle J, Jones KH, Gao G, York TP, Jackson-Cook C (2013) Epigenetic alterations and an increased frequency of micronuclei in women with fibromyalgia. Nurs Res Pract 2013:795784. doi:10.1155/2013/795784, PMID: 24058735
291. Rönnbäck L, Hansson E (2004) On the potential role of glutamate transport in mental fatigue. J Neuroinflammation 1:22, PMID: 15527505
292. Moylan S, Maes M, Wray NR, Berk M (2013) The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 18:595–606. doi:10.1038/mp.2012.33, PMID: 22525486
293. Anderson G, Maes M (2013) Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications. Curr Pharm Des [Epub ahead of print] PubMed PMID: 24180395.
294. Keane PC, Kurzawa M, Blain PG, Morris CM (2011) Mitochondrial dysfunction in Parkinson’s disease. Parkinsons Dis 2011:716871. doi:10.4061/2011/716871, PMID: 21461368
295. Hsu M, Srinivas B, Kumar J, Subramanian R, Andersen J (2005) Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson’s disease. J Neurochem 92:1091–103, PMID: 15715660
296. Auchère F, Santos R, Planamente S, Lesuisse E, Camadro JM (2008) Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich’s ataxia. Hum Mol Genet 17:2790–802. doi:10.1093/hmg/ddn178, PMID: 18562474
297. Friedlich AL, Smith MA, Zhu X, Takeda A, Nunomura A, Moreira PI, Perry G (2009) Oxidative stress in Parkinson’s disease. Open Pathology J 3:38–42
298. Jomova K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicology 283:65–87. doi:10.1016/j.tox.2011.03.001, PMID: 21414382
299. Valko M, Morris H, Cronin MT (2005) Metals, toxicity and oxidative stress. Curr Med Chem 12:1161–208, PMID: 15892631
300. Morris G, Maes M (2014) Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis 29:19–36. doi:10.1007/s11011-013-9435-x, PMID: 24557875
301. Sadowska AM, Manuel-Y-Keenoy B, De Backer WA (2007) Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm Pharmacol Ther 20:9–22, PMID: 16458553
302. Cotgreave IA (1997) N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol 38:205–27, PMID: 8895810
303. Jain A, Mårtensson J, Stole E, Auld PA, Meister A (1991) Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci U S A 88:1913–7, PMID: 2000395
304. Zeevalk GD, Razmpour R, Bernard LP (2008) Glutathione and Parkinson’s disease: is this the elephant in the room? Biomed Pharmacother 62:236–49
305. De Flora S, Bennicelli C, Camoirano A, Serra D, Romano M, Rossi GA, Morelli A, De Flora A (1985) In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic com-pounds. Carcinogenesis 6:1735–45
306. Hoffer E, Baum Y, Tabak A, Taitelman U (1996) N-acetylcysteine increases the glutathione content and protects rat alveolar type II cells against paraquat-induced cytotoxicity. Toxicol Lett 84:7–12
307. Corcoran GB, Wong BK (1986) Role of glutathionein prevention of acetaminophen-induced hepatotoxicity by N-acetyl-l-cysteine in vivo: studies with N-acetyl-d-cysteine in mice. J Pharmacol Exp Ther 238:54–61
308. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA (2007) N-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 7:355–9
309. Samuni Y, Goldstein S, Dean OM, Berk M (2013) The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta 1830:4117–29. doi:10.1016/j.bbagen.2013.04.016
310. Arranz L, Fernández C, Rodríguez A, Ribera JM, De la Fuente M (2008) The glutathione precursor N-acetylcysteine improves immune function in postmenopausal women. Free Radic Biol Med 45:1252–62. doi:10.1016/j.freeradbiomed.2008.07.014
311. Banner W Jr, Koch M, Capin DM, Hopf SB, Chang S, Tong TG (1986) Experimental chelation therapy in chromium, lead, and boron intoxication with N-acetylcysteine and other compounds. Toxicol Appl Pharmacol 83:142–7
312. de Quay B, Malinverni R, Lauterburg BH (1992) Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 6:815–9
313. Akerlund B, Jarstrand C, Lindeke B, Sonnerborg A, Akerblad AC, Rasool O (1996) Effect of n-acetylcysteine (NAC) treatment onHIV-1 infection: a double-blind placebo-controlled trial. Eur J Clin Pharmacol 50:457–61
314. Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Deresinski SC, Herzenberg LA (1997) Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci U S A 94:1967–72
315. Chen F, Lewis W, Hollander JM, Baseler W, Finkel MS (1985) N-acetylcysteine reverses cardiac myocyte dysfunction in HIV-Tat proteinopathy. J Appl Physiol 113:105–13. doi:10.1152/japplphysiol.00068.2012
316. Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI (2008) N-acetyl cysteine for depressive symptoms in bipolar disorder—a double-blind randomized placebo-controlled trial. Biol Psychiatry 64:468–75. doi:10.1016/j.biopsych.2008.04.022, PMID: 18534556
317. Magalhães PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M (2011) N-acetylcysteine for major depressive episodes in bipolar disorder. Rev Bras Psiquiatr 33:374–8, PMID: 22189927
318. Berk M, Dean O, Cotton SM, Gama CS, Kapczinski F, Fernandes BS, Kohlmann K, Jeavons S, Hewitt K, Allwang C, Cobb H, Bush AI, Schapkaitz I, Dodd S, Malhi GS (2011) The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. J Affect Disord 135:389–94. doi:10.1016/j.jad.2011.06.005
319. Farokhnia M, Azarkolah A, Adinehfar F, Khodaie-Ardakani MR, Hosseini SM, Yekehtaz H, Tabrizi M, Rezaei F, Salehi B, Sadeghi SM, Moghadam M, Gharibi F, Mirshafiee O, Akhondzadeh S (2013) N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study. Clin Neuropharmacol 36:185–92
320. Ghanizadeh A, Moghimi-Sarani E (2013) A randomized double blind placebo controlled clinical trial of N-acetylcysteine added to risperidone for treating autistic disorders. BMC Psychiatry 13:196. doi:10.1186/1471-244X-13-196
321. Child DF, Hudson PR, Jones H, Davies GK, De P, Mukherjee S, Brain AM, Williams CP, Harvey JN (2004) The effect of oral folic acid on glutathione, glycaemia and lipids in type 2 diabetes. Diabetes Nutr Metab 17:95–102
322. Chanson A, Rock E, Martin JF, Liotard A, Brachet P (2007) Preferential response of glutathione-related enzymes to folate-dependent changes in the redox state of rat liver. Eur J Nutr 46:204–12
323. Papakostas GI, Shelton RC, Zajecka JM, Etemad B, Rickels K, Clain A, Baer L, Dalton ED, Sacco GR, Schoenfeld D, Pencina M, Meisner A, Bottiglieri T, Nelson E, Mischoulon D, Alpert JE, Barbee JG, Zisook S, Fava M (2012) l-Methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry 169:1267–74
324. Reynolds EH (2002) Folic acid, ageing, depression, and dementia. BMJ 324:1512–5, PMID: 12077044
325. Passeri M, Cucinotta D, Abate G, Senin U, Ventura A, Stramba BM, Diana R, La Greca P, Le Grazie C (1993) Oral 5′-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Aging 5:63–71
326. Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T (1997) Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 154:426–8
327. Guaraldi GP, Fava M, Mazzi F, la Greca P (1993) An open trial of methyltetrahydrofolate in elderly depressed patients. Ann Clin Psychiatry 5:101–5
328. Stahl SM (2007) Novel therapeutics for depression: l-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent. CNS Spectr 12:739–44, PMID: 17934378
329. Liu J (2008) The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview. Neurochem Res 33:194–203
330. Valdecantos MP, Pérez-Matute P, González-Muniesa P, Prieto-Hontoria PL, Moreno-Aliaga MJ, Martínez JA (2012) Lipoic acid improves mitochondrial function in nonalcoholic steatosis through the stimulation of sirtuin 1 and sirtuin 3. Obesity (Silver Spring) 20:1974–83
331. Schmelzer C, Lindner I, Rimbach G, Niklowitz P, Menke T, Döring F (2008) Functions of coenzyme Q10 in inflammation and gene expression. Biofactors 32:179–83
332. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2009) Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro-Endocrinol Lett 30:462–9
333. Aboul-Fotouh S (2013) Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats. Pharmacol, Biochem Behav 104:105–12
334. Forester BP, Zuo CS, Ravichandran C, Harper DG, Du F, Kim S, Cohen BM, Renshaw PF (2012) Coenzyme Q10 effects on creatine kinase activity and mood in geriatric bipolar depression. J Geriatr Psychiatry Neurol 25:43–50. doi:10.1177/0891988712436688, PMID: 22467846
335. Jeong YY, Park HJ, Cho YW, Kim EJ, Kim GT, Mun YJ, Lee JD, Shin JH, Sung NJ, Kang D, Han J (2012) Aged red garlic extract reduces cigarette smoke extract-induced cell death in human bronchial smooth muscle cells by increasing intracellular glutathione levels. Phytother Res 26:18–25. doi:10.1002/ptr.3502
336. Rodríguez-Ramiro I, Ramos S, Bravo L, Goya L, Martín MÁ (2011) Procyanidin B2 and a cocoa polyphenolic extract inhibit acrylamide-induced apoptosis in human Caco-2 cells by preventing oxidative stress and activation of JNK pathway. J Nutr Biochem 22:1186–94. doi:10.1016/j.jnutbio.2010.10.005
337. Kansanen E, Kuosmanen SM, Leinonen H, Levonen AL (2013) The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol 1:45–9, PMID: 24024136
338. Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M (2012) New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates–Nrf2 activators and GSK-3 inhibitors. Inflammopharmacol 20:127–50
339. Nguyen T, Sherratt PJ, Pickett CB (2003) Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 43:233–60
340. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, Talalay P (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A 99:11908–13
341. Harvey CJ, Thimmulappa RK, Singh A, Blake DJ, Ling G, Wakabayashi N, Fujii J, Myers A, Biswal S (2009) Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic Biol Med 46:443–53. doi:10.1016/j.freeradbiomed.2008.10.040
342. Tsai CC, Chen HS, Chen SL, Ho YP, Ho KY, Wu YM, Hung CC (2005) Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J Periodontal Res 40:378–84
343. Dias VV, Brissos S, Cardoso C, Andreazza AC, Kapczinski F (2009) Serum homocysteine levels and cognitive functioning in euthymic bipolar patients. J Affect Disord 113:285–90
344. Godman CA, Chheda KP, Hightower LE, Perdrizet G, Shin DG, Giardina C (2010) Hyperbaric oxygen induces a cytoprotective and angiogenic response in human microvascular endothelial cells. Cell Stress Chaperones 15:431–42
345. Thom SR (1985) Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol 106:988–95. doi:10.1152/japplphysiol.91004.2008, PMID: 18845776
346. Soejima Y, Ostrowski RP, Manaenko A, Fujii M, Tang J, Zhang JH (2012) Hyperbaric oxygen preconditioning attenuates hyperglycemia enhanced hemorrhagic transformation after transient MCAO in rats. Med Gas Res 2:9
347. Avtan SM, Kaya M, Orhan N, Arslan A, Arican N, Toklu AS, Gürses C, Elmas I, Kucuk M, Ahishali B (2011) The effects of hyperbaric oxygen therapy on blood-brain barrier permeability in septic rats. Brain Res 1412:63–72. doi:10.1016/j.brainres.2011.07.020
348. Haapaniemi T, Sirsjö A, Nylander G, Larsson J (1995) Hyperbaric oxygen treatment attenuates glutathione depletion and improves metabolic restitution in postischemic skeletal muscle. Free Radic Res 23:91–101
349. Purucker E, Lutz J (1992) Effect of hyperbaric oxygen treatment and perfluorochemical administration on glutathione status of the lung. Adv Exp Med Biol 317:131–6
350. Li Q, Li J, Zhang L, Wang B, Xiong L (2007) Preconditioning with hyperbaric oxygen induces tolerance against oxidative injury via increased expression of heme oxygenase-1 in primary cultured spinal cord neurons. Life Sci 80:1087–93. doi:10.1016/j.lfs.2006.11.043
351. Rothfuss A, Speit G (2002) Investigations on the mechanism of hyperbaric oxygen (HBO)-induced adaptive protection against oxidative stress. Mutat Res 508:157–65
352. Speit G, Dennog C, Eichhorn U, Rothfuss A, Kaina B (2000) Induction of heme oxygenase-1 and adaptive protection against the induction of DNA damage after hyperbaric oxygen treatment. Carcinogenesis 21:1795–9
353. Surh YJ, Kundu JK, Na HK (2008) Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 74:1526–39
354. Biswas SK, McClure D, Jimenez LA, Megson IL, Rahman I (2005) Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal 7:32–41
355. Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, Rahman I (2008) Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smokemediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 294:L478–488
356. Garg R, Gupta S, Maru GB (2008) Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: mechanism of its anti-initiating action. Carcinogenesis 29:1022–32
357. Natarajan VT, Singh A, Kumar AA (2010) Transcriptional upregulation of Nrf2-dependent phase II detoxification genes in the involved epidermis of vitiligo vulgaris. J Invest Dermatol 130:2781–9
358. Shen G, Xu C, Hu R (2006) Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin. Mol Cancer Ther 5:39–51
359. McNally SJ, Harrison EM, Ross JA, Garden OJ, Wigmore SJ (2007) Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med 19:165–72
360. Rushworth SA, Ogborne RM, Charalambos CA, O’Connell MA (2006) Role of protein kinase C δ in curcumin-induced antioxidant response element-mediated gene expression in human monocytes. Biochem Biophys Res Commun 341:1007–16
361. Sanmukhani J, Satodia V, Trivedi J, Patel T, Tiwari D, Panchal B, Goel A, Tripathi CB (2013) Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res doi:. doi:10.1002/ptr.5025
362. Kulkarni S, Dhir A, Akula KK (2009) Potentials of curcumin as an antidepressant. Sci World J 9:1233–41. doi:10.1100/tsw.2009.137
363. Gupta A, Vij G, Sharma S, Tirkey N, Rishi P, Chopra K (2009) Curcumin, a polyphenolic antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model. Immunobiol 214:33–9
364. Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, De Galarreta CM, Cuadrado A (2004) Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 279:8919–29
365. Kong AN, Yu R, Hebbar V, Chen C, Owuor E, Hu R, Ee R, Mandlekar S (2001) Signal transduction events elicited by cancer prevention compounds. Mutat Res 480–481:231–41
366. Wondrak GT, Cabello CM, Villeneuve NF, Zhang S, Ley S, Li Y, Sun Z, Zhang DD (2008) Cinnamoyl-based Nrf2-activators targeting human skin cell photo-oxidative stress. Free Radic Biol Med 45:385–95
367. Moriya J, Chen R, Yamakawa J, Sasaki K, Ishigaki Y, Takahshi T (2011) Resveratrol improves hippocampal atrophy in chronic fatigue mice by enhancing neurogenesis and inhibiting apoptosis of granular cells. Biol Pharm Bull 34:354–9
368. Niu K, Hozawa A, Kuriyama S, Ebihara S, Guo HM, Nakaya N, Ohmori-Matsuda K, Takahashi H, Masamune Y, Asada M, Sasaki S, Arai H, Awata S, Nagatomi R, Tsuji I (2009) Green tea consumption is associated with depressive symptoms in the elderly. Am J Clin Nutr 90:1615–22
369. Han SG, Han SS, Toborek M, Hennig B (2012) EGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genes. Toxicol Appl Pharmacol 261:181–8
370. Steele ML, Fuller S, Patel M, Kersaitis C, Ooi L, Münch G (2013) Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells. Redox Biol 1:441–5. doi:10.1016/j.redox.2013.08.006
371. Lin SX, Lisi L, Russo CD, Polak PE, Sharp A, Weinberg G, Kalinin S, Feinstein DL (2011) The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1. ASN Neuro 3:e00055. doi:10.1042/AN20100033
372. Lukashev M, Zeng M, Goelz S, Lee D, Linker R, Drukach B, VanDam A (2007) Activation of Nrf2 and modulation of disease progression in EAE models by BG-12 (dimethyl fumarate) suggests a novel mechanism of action combining anti-inflammatory and neuroprotective modalities. Mult Scler 13:149
373. Linker RA, Gold R (2013) Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects. Curr Neurol Neurosci Rep 13:394. doi:10.1007/s11910-013-0394-8
374. Moharregh-Khiabani D, Linker RA, Gold R, Stangel M (2009) Fumaric Acid and its esters: an emerging treatment for multiple sclerosis. Curr Neuropharmacol 7:60–64. doi:10.2174/157015909787602788
375. Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Yang M, Eraksoy M, Meluzinova E, Rektor I, Dawson KT, Sandrock AW, O’Neil GN, BG-12 Phase IIb Study Investigators (2008) Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet 372:1463–72
376. Dodd S, Maes M, Anderson G, Dean O, Moylan S, Berk M (2013) Putative neuroprotective agents in major psychoses. Prog Neuropsychopharmacol Biol Psychiatry 42:135–145